http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f4909bd728711bb0433c054d6dc94e4
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Marynen |
| name | Peter Marynen |
| given-name | Peter |
| organization-name | University of Leuven Center for Human Genetics , , Campus Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium Human Genome Laboratory, Center for Human GeneticsUniversity of LeuvenLeuven, Belgium From the Departments of Pathology, Clinical Chemistry, Microbiology and Immunology, and Molecular Diagnostics, Center of Medical Genetics and Pediatric Oncology, Ghent University Hospital, Belgium; the Department of Human Genetics and Flanders Interuniversity Institute for Biotechnology, Division for Morphology and Molecular Pathology, Catholic University of Leuven, Belgium; and the Departments of Pathology, Human Genetics, and Pediatric Oncology, University Medical Center Nijmegen, the Netherlands. Katholieke Universiteit Leuven, Faculteit Geneeskunde–Campus Gasthuisberg, Departement Moleculaire Celbiologie, Afdeling Farmacologie, Leuven, Belgium; Katholieke Universiteit Leuven, Faculteit Geneeskunde–Campus Gasthuisberg, Centrum voor Menselijke Erfelijkheid, Leuven, Belgium; Universiteit Gent, Faculteit Geneeskunde, Vakgroep Biochemie (VIB), Gent, Belgium; Katholieke Universiteit Nijmegen, CAOS/CAMM Center, Nijmegen, The Netherlands; and Universität Heidelberg, Medizinische Fakultät,... Department of Human Genetics, Flanders Interuniversity Institute for Biotechnology (VIB), University of Leuven, 3000 Leuven, Belgium; and From the Center for Human Genetics and Flanders Interuniversity Institute of Biotechnology, and the Department of Pediatrics, University of Leuven, Leuven, Belgium; the Hematology and Bone Marrow Transplantation Unit, University of Perugia, Perugia, Italy; the Department of Hematology, AZ St Jan, Brugge, Belgium; and the Department of Hemato-Oncology, CHR Citadelle, Liege, Belgium. Human Genome Laboratory; Department of Human Genetics; KU Leuven Belgium Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium;; VIB Department of Molecular and Developmental Genetics, VIB, Leuven, Belgium; From the Department of Oncology and Hematology, University Hospital Eppendorf, Hamburg, Germany; Center for Human Genetics and Flanders Interuniversity Institute for Biotechnology, University of Leuven, Leuven, Belgium; the Department of Hematology, University of Salamanca, Salamanca, Spain; and the Department of Pathology, University of Leuven, Belgium. From the Department of Oncology and Hematology, University Hospital Eppendorf, Hamburg, Germany; the Center for Human Genetics and Flanders Interuniversity Institute for Biotechnology and the Departments of Pathology and Hematology, University of Leuven, Leuven, Belgium; and the Department of Pathology, Centre Hospitalier Universitaire Henri Mondor, Créteil, France. 1Human Genetics, Departments of; 4VIB Department of Molecular and Developmental Genetics, VIB, Leuven, Belgium 16Department of Human Genetics and VIB, Katholieke Universiteit Leuven, 3000 Leuven, Belgium From the Center for Human Genetics, Flanders Interuniversity Institute for Biotechnology, University of Leuven, Leuven, Belgium; Laboratoire de Génétique, Faculté de Médecine, Nice; UEFCT, Hôpital Pasteur, Nice; and Service de Pédiatrie, Hôpital de l'Archet, Nice, France. Human Genome Laboratory, VIB Center for the Biology of Disease, 2Human Genome Laboratory, KU Leuven, 3Laboratory for Reproductive Genomics, Center for Human Genetics, KU Leuven and 4Thromb-X, Department of Molecular and Cellular Medicine, B-3000 Leuven, Belgium From the Department of Pathology and Laboratory Medicine, St. Jude Children's Research Hospital, and the Department of Pediatrics, University of Tennessee, College of Medicine, Memphis, TN; the Center for Human Genetics and Flanders Interuniversity Institute of Biotechnology, and the Department of Pathology, University of Leuven, Leuven, Belgium; and the Department of Human Genetics, University of Kiel, Kiel, Germany. Authors' Affiliations: 1Department of Human Genetics and 2Department of General Medical Oncology, and 3Flanders Interuniversity Institute for Biotechnology (VIB), Catholic University of Leuven; 4Department of Pathology, University Hospitals of Leuven, Leuven, Belgium; 5Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 6Department of Pathology, Institute Bergonié, Bordeaux, France; 7Institute of Pathology, University of Lausanne, Lausanne, Switzerland; and 8Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands; Authors' Affiliations: 1Department of Human Genetics and 2Department of General Medical Oncology, and 3Flanders Interuniversity Institute for Biotechnology (VIB), Catholic University of Leuven; 4Department of Pathology, University Hospitals of Leuven, Leuven, Belgium; 5Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 6Department of Pathology, Institute Bergonié, Bordeaux, France; 7Institute of Pathology, University of Lausanne, Lausanne, Switzerland; and 8Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands From the Human Genome Laboratory, Center for Human Genetics—Flanders Interuniversity Institute for Biotechnology (VIB), and the Department of Hematology, University of Leuven, Belgium; and the Department of Genetics, University of Navarra, Pamplona, Spain. †Human Genome Laboratory, Molecular Genetics, Center for Human Genetics, University of Leuven, Leuven, Belgium;; ‡Human Genome Laboratory, Department of Molecular and Developmental Genetics, Flanders Institute for Biotechnology, Leuven, Belgium; From the Department of Human Genetics, Flanders Interuniversity Institute for Biotechnology (VIB), Leuven, Belgium; Departments of Human Genetics and Hematology, University of Leuven, Leuven, Belgium; and Department of Genetics, University of Navarra, Pamplona, Spain. KU Leuven Department of Human Genetics Leuven Belgium From the Center for Human Genetics, Flanders Interuniversity Institute for Biotechnology, University of Leuven, Leuven, Belgium; Hematology Laboratory, University Victor Segalen Bordeaux 2, Bordeaux, France; Hôpital Cantonal Universitaire, Genève, Switzerland; and Centre Hospitalier Régional de Nantes, Nantes, France. From the Center for Human Genetics, Flemish Interuniversity Institute for Biotechnology, University of Leuven, Leuven, Belgium; Servei d'Hematologia, Hospital de Sant Pau, Barcelona, Spain; Cryobiology and Cell Therapy Department, Hospital “Duran i Reynals,” Barcelona, Spain; Hematology and Bone Marrow Transplantation Unit, University of Perugia, Italy; and the Department of Hematology, AZ St Jan, Brugge, Belgium. 1Center for Human Genetics, Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Department of Human Genetics, University of Leuven, B-3000 Leuven, Belgium; Human Genome Laboratory Department of Human Genetics KU Leuven Leuven Belgium; Human Genome Laboratory VIB Center for the Biology of Disease Leuven Belgium From the Division of Hematology and the Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Center for Human Genetics-Flanders Interuniversity Institute of Biotechnology (VIB), University of Leuven, Belgium; and the DSMZ-German Collection of Microorganisms and Cell Cultures, Department of Human and Animal Cell Cultures, Braunschweig, Germany. 2Human Genetics, Flanders Interuniversity Institute for Biotechnology (VIB);; 3Center for Human Genetics and Center for Human Genetics, Flanders Interuniversity Institute for Biotechnology (VIB4), Department of Human Genetics, Leuven, Belgium 1Human Genome Laboratory, Department of Human Genetics, Flanders Interuniversity Institute for Biotechnology, University of Leuven, B-3000 Leuven, Belgium From the Department of Human Genetics, Flanders Interuniversity Institute for Biotechnology (VIB), the Department of Hematology, Universitaire Ziekenhuizen (UZ) Leuven, and the Department of Human Genetics, University of Leuven, Belgium; the Division of Hematology, Department of Medicine, Brigham and Women's Hospital, and the Department of Genetics, Harvard Medical School, Boston, MA. 4Department of Human Genetics, Flanders Interuniversity Institute for Biotechnology, University of Leuven, Leuven, Belgium; |
Incoming Links
Total number of triples: 205.